WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1891-01-01
- Employees
- 10K
- Market Cap
- -
Predictors of AAA Expansion and/or Rupture
Phase 4
Terminated
- Conditions
- Abdominal Aortic Aneurysm (AAA)
- Interventions
- Drug: Assess AAA rupture risk by PET-CTA scansDrug: 18F-fludeoxyglucose (FDG)Diagnostic Test: 11C-PBR28
- First Posted Date
- 2017-07-27
- Last Posted Date
- 2021-07-09
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 2
- Registration Number
- NCT03231397
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy
Phase 1
Completed
- Conditions
- MammoplastyBreast Implant Infection
- Interventions
- Other: Normal salineProcedure: Skin biopsyDrug: CefazolinProcedure: Bilateral skin- or nipple-sparing mastectomiesDevice: Breast implantDevice: Tissue expanderProcedure: Autologous flapOther: Acellular dermal matrix slingDrug: GentamicinDrug: Bacitracin
- First Posted Date
- 2017-07-11
- Last Posted Date
- 2019-02-08
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 19
- Registration Number
- NCT03213249
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Disseminating Public Health Evidence to Support Prevention and Control of Diabetes Among Local Health Departments
Not Applicable
Completed
- Conditions
- Organizational Support for Evidence-based Public Health
- Interventions
- Other: Dissemination of public health knowledge
- First Posted Date
- 2017-07-07
- Last Posted Date
- 2023-02-10
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 331
- Registration Number
- NCT03211832
- Locations
- 🇺🇸
Prevention Research Center, Brown School, Washington University in St. Louis, Saint Louis, Missouri, United States
Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
Phase 1
Completed
- Conditions
- Graft-versus-host-diseaseGraft Vs Host Disease
- Interventions
- First Posted Date
- 2017-07-05
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 10
- Registration Number
- NCT03207958
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Text Based Mobile Technology and Weight Loss
Not Applicable
Completed
- Conditions
- Obesity
- Interventions
- Behavioral: Control ConditionBehavioral: CareMessage™
- First Posted Date
- 2017-06-29
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 35
- Registration Number
- NCT03203655
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
Phase 1
Terminated
- Conditions
- Triple-negative Breast CarcinomaTriple Negative Breast CancerTriple Negative Breast NeoplasmsTNBC - Triple-Negative Breast Cancer
- Interventions
- Drug: DurvalumabBiological: Neoantigen DNA vaccineDevice: TDS-IM system (Inchor Medical Systems)Procedure: Peripheral blood draw
- First Posted Date
- 2017-06-26
- Last Posted Date
- 2024-05-28
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 18
- Registration Number
- NCT03199040
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Helping Poor Smokers Quit
Not Applicable
Completed
- Conditions
- Nicotine Dependence Tobacco ProductSmoking, CigaretteTobacco UseSmoking, TobaccoSmoking (Tobacco) AddictionTobacco; Use, RehabilitationNicotine Use DisorderSmoking, PipeTobacco Use CessationSmoking Cessation
- Interventions
- Behavioral: Specialized QuitlineBehavioral: Basic Needs Navigator
- First Posted Date
- 2017-06-21
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 1944
- Registration Number
- NCT03194958
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
Physical Therapy and Deep Brain Stimulation in Parkinson Disease
Not Applicable
Completed
- Conditions
- Parkinson Disease
- Interventions
- Behavioral: Physical Therapy
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 31
- Registration Number
- NCT03181282
- Locations
- 🇺🇸
Washington University in St. Louis School of Medicine - Program in Physical Therapy, Saint Louis, Missouri, United States
Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics
Phase 4
Withdrawn
- Conditions
- Postdural Puncture HeadacheCerebrospinal Fluid LeakSpinal; Puncture, Complications, Headache
- Interventions
- Drug: Lidocaine 4%Drug: Placebo
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2019-02-12
- Lead Sponsor
- Washington University School of Medicine
- Registration Number
- NCT03181464
- Locations
- 🇺🇸
Washington University in St Louis School of Medicine, Saint Louis, Missouri, United States
Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji
Not Applicable
Completed
- Conditions
- Soil Transmitted HelminthsLymphatic FilariasesScabiesImpetigo
- Interventions
- Drug: 2 drug dose - DADrug: 3 drug dose - IDA with second dose of ivermectinDrug: 3 drug dose - IDA
- First Posted Date
- 2017-06-06
- Last Posted Date
- 2020-12-31
- Lead Sponsor
- Washington University School of Medicine
- Target Recruit Count
- 4773
- Registration Number
- NCT03177993
- Locations
- 🇫🇯
Ministry of Health and Medical Services, Suva, Fiji
© Copyright 2025. All Rights Reserved by MedPath